(Q46767433)

25 December 2017

title

Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP. (English)

1 reference

25 December 2017

0 references

2

Daniel R Weinberger

1 reference

25 December 2017

Leah J Sartorius

1

1 reference

25 December 2017

Thomas M Hyde

3

1 reference

25 December 2017

Paul J Harrison

4

1 reference

25 December 2017

Joel E Kleinman

5

1 reference

25 December 2017

Barbara K Lipska

6

1 reference

25 December 2017

language of work or name

English

0 references

publication date

6 February 2008

1 reference

25 December 2017

published in

Neuropsychopharmacology

1 reference

25 December 2017

volume

33

1 reference

25 December 2017

issue

11

1 reference

25 December 2017

page(s)

2626-2634

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301669

exact match

0 references

cites work

Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

ESEfinder: A web resource to identify exonic splicing enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Molecular heterosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Pharmacology and functions of metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Identification of a genetic cluster influencing memory performance and hippocampal activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Metabotropic glutamate receptor agonists inhibit endogenous glutamate release from rat striatal synaptosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Predictive identification of exonic splicing enhancers in human genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Glutamate as a therapeutic target in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Critical factors in gene expression in postmortem human brain: Focus on studies in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Metabotropic glutamate receptor 3 (GRM3) gene variation is not associated with schizophrenia or bipolar affective disorder in the German population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

No evidence for association between polymorphisms in GRM3 and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Alternative splicing of human metabotropic glutamate receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

A metabotropic glutamate receptor agonist DCG-IV suppresses synaptic transmission at mossy fiber pathway of the guinea pig hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

Altered dimerization of metabotropic glutamate receptor 3 in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

7 January 2021

XIV World Congress on Psychiatric Genetics, October 28th–November 1st, 2006 Congress Centre Fiera Internazionate della Sardegna, Cagliari, Italy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

7 January 2021

Metabotropic glutamate receptor-mediated presynaptic depression at corticostriatal synapses involves mGLuR2 or 3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

7 January 2021

Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

7 January 2021

Schizophrenia genes - famine to feast

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301669

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301669

1 reference

25 December 2017

PubMed ID

18256595

1 reference

25 December 2017